...
首页> 外文期刊>Trials >Evaluation of interventions for informed consent for randomised controlled trials (ELICIT): protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey
【24h】

Evaluation of interventions for informed consent for randomised controlled trials (ELICIT): protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey

机译:评估随机对照试验(ELICIT)知情同意的干预措施:使用Delphi调查系统评估文献并鉴定核心结果集的方案

获取原文
           

摘要

Background The process of obtaining informed consent for participation in randomised controlled trials (RCTs) was established as a mechanism to protect participants against undue harm from research and allow people to recognise any potential risks or benefits associated with the research. A number of interventions have been put forward to improve this process. Outcomes reported in trials of interventions to improve the informed consent process for decisions about trial participation tend to focus on the ‘understanding’ of trial information. However, the operationalization of understanding as a concept, the tools used to measure it and the timing of the measurements are heterogeneous. A lack of clarity exists regarding which outcomes matter (to whom) and why. This inconsistency between studies results in difficulties when making comparisons across studies as evidenced in two recent systematic reviews of informed consent interventions. As such, no optimal method for measuring the impact of these interventions aimed at improving informed consent for RCTs has been identified. Methods/Design The project will adopt and adapt methodology previously developed and used in projects developing core outcome sets for assessment of clinical treatments. Specifically, the work will consist of three stages: 1) A systematic methodology review of existing outcome measures of trial informed consent interventions; 2) Interviews with key stakeholders to explore additional outcomes relevant for trial participation decisions; and 3) A Delphi study to refine the core outcome set for evaluation of trial informed consent interventions. All stages will include the stakeholders involved in the various aspects of RCT consent: users (that is, patients), developers (that is, trialists), deliverers (focusing on research nurses) and authorisers (that is, ethics committees). A final consensus meeting including all stakeholders will be held to review outcomes. Discussion The ELICIT study aims to develop a core outcome set for the evaluation of interventions intended to improve informed consent for RCTs for use in future RCTs and reviews, thereby improving the reliability and consistency of research in this area.
机译:背景技术获得参与随机对照试验(RCT)的知情同意的过程是为了保护参与者免受研究的不当伤害并允许人们认识到与研究相关的任何潜在风险或收益的机制。已经提出了许多干预措施来改善这一过程。在干预试验中报告的结果旨在改善知情同意程序以决定有关试验参与的结果,这些结果往往集中在对试验信息的“理解”上。但是,理解作为一个概念的可操作性,用于测量它的工具以及测量的时间是不同的。关于哪个结果重要(对谁)以及为什么重要尚不明确。研究之间的这种不一致导致在进行研究之间的比较时遇到困难,正如最近两次对知情同意干预的系统评价所证明的那样。因此,尚未找到衡量这些干预措施的效果的最佳方法,这些措施旨在改善RCT的知情同意。方法/设计该项目将采用和改编先前开发的方法,并在开发用于评估临床治疗的核心结果集的项目中使用。具体而言,该工作将包括三个阶段:1)对试验性知情同意干预措施的现有结果指标进行系统的方法学审查; 2)与主要利益相关者的访谈,以探索与试验参与决策相关的其他结果; 3)进行Delphi研究,以完善核心结果集以评估试验知情同意干预措施。所有阶段都将包括参与RCT同意各个方面的利益相关者:用户(即患者),开发人员(即试验者),交付者(专注于研究护士)和授权者(即道德委员会)。将举行包括所有利益相关者的最终共识会议,以审查结果。讨论ELICIT研究旨在开发一套评估干预措施的核心成果,旨在改善对RCT的知情同意,以供将来的RCT和审查使用,从而提高该领域研究的可靠性和一致性。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号